Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Tokyo - Delayed Quote JPY

Eisai Co., Ltd. (4523.T)

4,038.00
+62.00
+(1.56%)
At close: 3:30:00 PM GMT+9
Currency in JPY All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
741,751,000
741,751,000
744,402,000
756,226,000
645,942,000
Cost of Revenue
155,333,000
155,333,000
177,837,000
174,831,000
161,310,000
Gross Profit
586,417,000
586,417,000
566,566,000
581,395,000
484,632,000
Operating Expense
533,010,000
533,010,000
526,526,000
527,645,000
433,120,000
Operating Income
53,407,000
53,407,000
40,040,000
53,750,000
51,512,000
Net Non Operating Interest Income Expense
8,416,000
8,416,000
4,973,000
709,000
785,000
Pretax Income
61,823,000
61,823,000
45,012,000
54,458,000
52,296,000
Tax Provision
18,040,000
18,040,000
-11,824,000
8,741,000
9,990,000
Net Income Common Stockholders
42,406,000
42,406,000
55,432,000
47,954,000
41,942,000
Diluted NI Available to Com Stockholders
42,406,000
42,406,000
55,432,000
47,954,000
41,942,000
Basic EPS
158.38
147.86
193.31
167.27
585.36
Diluted EPS
158.38
147.86
193.31
167.25
585.16
Basic Average Shares
286,798.97
286,803
286,757
286,685
71,654
Diluted Average Shares
286,802.97
286,803
286,761
286,729
71,678.25
Total Operating Income as Reported
53,408,000
53,408,000
40,040,000
53,750,000
51,511,000
Total Expenses
688,343,000
688,343,000
704,363,000
702,476,000
594,430,000
Net Income from Continuing & Discontinued Operation
42,407,000
42,407,000
55,432,000
47,954,000
41,942,000
Normalized Income
42,407,000
42,407,000
55,432,000
47,954,000
41,942,000
Interest Income
10,804,000
10,804,000
7,239,000
2,401,000
2,145,000
Interest Expense
2,388,000
2,388,000
2,266,000
1,692,000
1,360,000
Net Interest Income
8,416,000
8,416,000
4,973,000
709,000
785,000
EBIT
64,211,000
64,211,000
47,278,000
56,150,000
53,656,000
EBITDA
103,609,000
103,609,000
87,259,000
94,548,000
89,423,000
Reconciled Cost of Revenue
155,333,000
155,333,000
177,837,000
174,831,000
161,310,000
Reconciled Depreciation
39,398,000
39,398,000
39,981,000
38,398,000
35,767,000
Net Income from Continuing Operation Net Minority Interest
42,407,000
42,407,000
55,432,000
47,954,000
41,942,000
Normalized EBITDA
103,609,000
103,609,000
87,259,000
94,548,000
89,423,000
Tax Rate for Calcs
0
0
0
0
0
3/31/2021 - 1/4/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

4502.T Takeda Pharmaceutical Company Limited
4,300.00
+2.09%
 
MRKC.DU Merck KGaA
22.80
0.00%
 
MRKC.SG Merck KGaA
22.80
0.00%
 
EVT.VI Evotec SE
6.35
+1.76%
 
BON.F Boiron SA
23.85
+1.27%
 
BIO.RO Biofarm S.A.
0.6700
0.00%
 
R5XA.BE AcelRx Pharmaceuticals Inc
0.4275
+2.40%
 
MRKC.MU Merck KGaA
23.20
0.00%
 
131030.KQ DHP Korea Co., Ltd.
6,140.00
-1.44%
 
MRKC.F Merck KGaA
22.80
-1.72%